Tüdőrák: nyitott vizsgálatok itt: Finnország

16 nyitott vizsgálatnak van helyszíne itt: Finnország. Regiszteradat; hogy ki vehet részt, azt csak a vizsgálat csapata dönti el.

NCT06623422
A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)
Kísérleti kezelés · 3. fázis · Merck Sharp & Dohme LLC
Oulu University Hospital, Oulu · Turku University Hospital, Turku
Regiszter frissítve: 2026-11-09
NCT07144280
A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)
Kísérleti kezelés · 3. fázis · Pfizer
HUS-Yhtymae, Helsinki · Kuopio University Hospital, Kuopio · Turku University Hospital, Turku · Vaasa Central Hospital, Vaasa
Regiszter frissítve: 2026-11-05
NCT07563738
A 2-part Phase 1/2 Open-label Trial on ODM-212
Kísérleti kezelés · 1/2. fázis · Orion Corporation, Orion Pharma
Helsinki University Hospital, Helsinki · Turku University Hospital, Turku
Regiszter frissítve: 2026-11-05
NCT06452277
A Study to Learn More About How Well Sevabertinib Works and How Safe it is Compared With Standard Treatment, in Participants Who Have Advanced Non-small Cell Lung Cancer (NSCLC) With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
Kísérleti kezelés · 3. fázis · Bayer
Docrates Oy, Helsinki · Turku University Hospital, Turku
Regiszter frissítve: 2026-11-04
NCT06667076
A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
Kísérleti kezelés · 2. fázis · Janssen Research & Development, LLC
HUS-Yhtymae, Helsinki · Oulu University Hospital, Oulu · Turku University Hospital, Turku
Regiszter frissítve: 2026-11-03
NCT04613596
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
Kísérleti kezelés · 2/3. fázis · Mirati Therapeutics Inc.
Docrates Oy, Helsinki · Tampere University Hospital, Tampere
Regiszter frissítve: 2026-10-30
NCT07472517
DAREON ® -Lung-1: A Study in People With Advanced Small Cell Lung Cancer to Compare Obrixtamig Plus Atezolizumab, Carboplatin, and Etoposide Treatment With Standard Chemoimmunotherapy
Kísérleti kezelés · 3. fázis · Boehringer Ingelheim
Pohjois-Savon hyvinvointialue, Kuopio · Oulu University Hospital, Oulu · Turku University Hospital, Turku
Regiszter frissítve: 2026-10-28
NCT07361510
A Study to Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participants With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%. (ROSETTA Lung-202)
Kísérleti kezelés · 3. fázis · Bristol-Myers Squibb
Kuopio University Hospital, Kuopio · Tampere University Hospital, Tampere · Vaasa Central Hospital, Vaasa
Regiszter frissítve: 2026-10-23
NCT07099898
A Study of GSK5764227 in Participants With Relapsed Small Cell Lung Cancer (SCLC) [EMBOLD SCLC-301]
Kísérleti kezelés · 3. fázis · GlaxoSmithKline
Vaasa
Regiszter frissítve: 2026-10-20
NCT07252739
KEYMAKER-U01 Substudy 01J: A Study of Pembrolizumab Plus MK-1084 in Participants With Non-Small Cell Lung Cancer (NSCLC) With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) G12C Mutations (MK-3475-01J/KEYMAKER-U01J)
Kísérleti kezelés · 2. fázis · Merck Sharp & Dohme LLC
HUS-Yhtymae, Helsinki · Kuopio University Hospital, Kuopio · Turku University Hospital, Turku · Vaasa Central Hospital, Vaasa
Regiszter frissítve: 2026-09-02
2026-525513-31-00
Does a higher radiation dose prolong survival of patients with limited-stage small cell lung cancer receiving immunotherapy after chemotherapy and radiation therapy (DAHRTS trial)?
Kísérleti kezelés · 3. fázis · Norges Teknisk-Naturvitenskapelige Universitet NTNU
Tampere University Hospital, Tampere · Vaasa Central Hospital, Vaasa
Regiszter frissítve: 2026-08-24
NCT07740239
A COhort Study on Factors Leading to Vulnerability in Adult Patients With Serious Medical cOnditionS: the COSMOS-I Trial
Kutatás · Tampere University Hospital
Tampere University Hospital, Tampere
Regiszter frissítve: 2026-07-31
NCT07331519
Integrating Smoking Cessation With Low-dose CT-screening for Lung Cancer
Kísérleti kezelés · Oulu University Hospital
Helsinki University Hospital, Helsinki · Oulu University Hospital, Oulu · Tampere University Hospital, Tampere · Turku University Hospital, Turku · Vaasa Central Hospital, Vaasa
Regiszter frissítve: 2026-02-06
2025-523965-97-00
The Expression of Fibroblast Activation Protein in Patients with Non-Small Cell Lung Cancer Patients
Kísérleti kezelés · 2. fázis · Turku University Hospital
Turku University Hospital, Turku
Regiszter frissítve: 2025-12-16
NCT05094843
The Cardiac Stress and Electrocardiographic Changes Caused by Lung Cancer Surgery
Kutatás · Tampere University Hospital
Heart Hospita, Tampere University Hospital, Tampere
Regiszter frissítve: 2025-09-10
NCT05212103
PET Imaging of Cancer Patients Using 68Ga-DOTA-Siglec-9
Kutatás · Turku University Hospital
Turku University Hospital, Turku PET Centre, Turku
Regiszter frissítve: 2024-12-04

Minden vizsgálat (Tüdőrák) és a térkép

Ez az oldal nem orvosi tanács. Mielőtt egy vizsgálatot megkeresel, beszélj az orvosoddal.

Hibát jelzek